查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571988

世界論文診斷市場

Paper Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，美國的全球論文診斷市場預計將達到 138 億美元

全球紙本診斷市場預計 2023 年為 88 億美元，預計到 2030 年將達到 138 億美元，2023 年至 2030 年複合年成長率為 6.6%。橫向流動化驗套件是本報告分析的細分市場之一，預計複合年成長率為 6.2%，到分析期結束時將達到 67 億美元。在分析期間，量油尺細分市場的複合年成長率預計為 7.4%。

美國市場預計24億美元，中國預計複合年成長率6.2%

預計 2023 年美國紙本診斷市場規模將達 24 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達22億美元，2023-2030年分析期間複合年成長率為6.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.8% 和 5.6%。在歐洲，德國的複合年成長率預計為 5.1%。

全球論文診斷市場—主要趨勢與促進因素總結

什麼是論文診斷？

紙本診斷是指使用紙本設備進行醫學測試和疾病檢測。這些裝置通常由纖維素和其他多孔材料製成，價格便宜、易於使用且一次性。作為傳統實驗室測試的經濟有效的替代方案，論文診斷越來越受歡迎，特別是在資源有限的環境中。它通常用於側流檢測，例如妊娠測試和瘧疾、COVID-19 和 HIV 等感染疾病的快速診斷測試。這些設備簡單且便攜，非常適合及時診斷至關重要的就地檢驗。此外，Essay Diagnostics 可生物分解性、環保，且操作所需的試劑和設備最少。

科技進步如何提升診斷論文的能力？

技術的進步大大擴展了紙本診斷的應用範圍。微流體的創新使得更複雜的診斷方法得以開發，這些方法可以透過使少量流體流過蝕刻在紙張上的通道來同時執行多項測試。將比色、電化學和螢光檢測方法納入紙本診斷提高了靈敏度和準確性，從而獲得更可靠的結果。此外，隨著可以檢測血液、唾液和尿液中特定生物標記的紙質生物感測器的發展，紙本診斷正在成為早期疾病檢測和監測的強大工具。這些進步為個人化醫療保健開闢了新的可能性，使個人能夠家用中進行診斷測試並立即獲得結果，而無需實驗室。

全球健康計劃和遠距醫療趨勢如何塑造市場？

技術創新正在改變紙本診斷產業，主要是透過微流體、生物感測器和檢測方法的進步。微流體使得能夠在小型攜帶式紙質平台上處理複雜分析的設備得以開發。這些進步使得創建可以同時執行多項測試的設備成為可能，從而大大增加了論文診斷的多功能性。此外，紙本診斷中生物感測器的使用擴大了可檢測的病理範圍，從感染疾病到糖尿病等慢性病。比色、螢光和電化學檢測技術的整合進一步提高了這些測試的準確性和可靠性，增加了它們在已開發市場和新興市場的吸引力。這些技術突破使得設計出價格實惠的攜帶式診斷工具成為可能，這些工具可以在資源匱乏的環境中使用，並在醫療環境中提供快速可靠的結果。

紙本診斷市場成長的驅動力是什麼？

論文診斷的需求在很大程度上受到全球健康舉措的影響，這些計劃致力於改善偏遠和服務不足地區的醫療保健服務。世界衛生組織 (WHO) 和非政府組織等組織擴大倡導可在衛生基礎設施有限的地區使用負擔得起的診斷工具。這些診斷的低成本和便攜性使其適合傳統實驗室測試無法進行或無法進行的環境。這些工具對於及時發現瘧疾、結核病和愛滋病毒等疾病至關重要，並有助於減少感染疾病的傳播。此外，COVID-19 大流行凸顯了家庭檢測和遠端醫療的重要性，並加速了紙本診斷的採用。

對照護現場診斷的需求不斷增加，特別是在醫療基礎設施有限的地區，刺激了紙本診斷設備的採用。微流體、生物感測器和檢測方法的技術進步顯著提高了紙本平台上進行的測試的靈敏度、準確性和範圍。此外，全球對經濟實惠且永續的醫療保健解決方案的推動增加了對經濟高效、攜帶式和環保診斷的需求。向遠距醫療保健和個人化醫療的轉變、感染疾病和慢性病盛行率的上升也促進了市場的成長。隨著政府、非政府組織和醫療機構繼續投資改善醫療服務，特別是在資源匱乏的環境中，紙本診斷市場預計將大幅擴張。

受訪企業範例（44家知名企業）

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13853

Global Paper Diagnostics Market to Reach US$13.8 Billion by 2030

The global market for Paper Diagnostics estimated at US$8.8 Billion in the year 2023, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth in the Dipsticks segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 6.2% CAGR

The Paper Diagnostics market in the U.S. is estimated at US$2.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Paper Diagnostics Market – Key Trends & Drivers Summarized

What Are Paper Diagnostics and Why Are They Gaining Traction in Healthcare?

Paper diagnostics refers to the use of paper-based devices for medical testing and disease detection. These devices are typically made from cellulose or other porous materials that are inexpensive, easy to use, and disposable. Paper diagnostics has gained popularity, particularly in resource-limited settings, as they provide a cost-effective alternative to traditional laboratory-based tests. They are often used in lateral flow assays, such as pregnancy tests or rapid diagnostic tests for infectious diseases like malaria, COVID-19, or HIV. The simplicity and portability of these devices make them ideal for point-of-care testing, where timely diagnosis is crucial. In addition, paper diagnostics are environmentally friendly, being biodegradable and requiring minimal reagents or equipment for operation.

How Are Technological Advancements Enhancing the Capabilities of Paper Diagnostics?

Technological advancements have greatly expanded the applications of paper diagnostics. Innovations in microfluidics, where small volumes of fluids are directed through channels etched into paper, have made it possible to develop more complex diagnostics that can perform multiple tests simultaneously. The incorporation of colorimetric, electrochemical, and fluorescent detection methods into paper diagnostics has improved their sensitivity and accuracy, allowing for more reliable results. In addition, the development of paper-based biosensors, which can detect specific biomarkers in blood, saliva, or urine, is making paper diagnostics a powerful tool for early disease detection and monitoring. These advancements have opened up new possibilities for personalized healthcare, allowing individuals to perform diagnostic tests at home and receive instant results without the need for a laboratory.

How Are Global Health Initiatives and Remote Healthcare Trends Shaping the Market?

Technological innovations are transforming the paper diagnostics industry, primarily through advancements in microfluidics, biosensors, and detection methods. Microfluidics has allowed the development of devices that can handle complex assays on a small, portable paper platform. These advancements enable the creation of devices that can simultaneously conduct multiple tests, significantly improving the versatility of paper diagnostics. Moreover, the use of biosensors embedded in paper diagnostics has expanded the range of detectable conditions, from infectious diseases to chronic illnesses like diabetes. The integration of colorimetric, fluorescent, and electrochemical detection techniques further improves the accuracy and reliability of these tests, enhancing their appeal in both developed and developing markets. These technological breakthroughs make it possible to design affordable, portable diagnostic tools that can be used in low-resource settings and provide quick, reliable results at the point of care.

What Is Driving Growth in the Paper Diagnostics Market?

The demand for paper diagnostics is heavily influenced by global health initiatives that focus on improving healthcare access in remote and underserved regions. Organizations such as the World Health Organization (WHO) and NGOs are increasingly advocating for affordable diagnostic tools that can be used in areas with limited medical infrastructure. Paper diagnostics, being low-cost and easy to transport, are well-suited to these environments, where traditional laboratory tests may be inaccessible or unaffordable. These tools are crucial for the timely detection of diseases like malaria, tuberculosis, and HIV, helping to curb the spread of infectious diseases. Additionally, the COVID-19 pandemic highlighted the importance of at-home testing and telemedicine, accelerating the adoption of paper diagnostics.

The increasing demand for point-of-care diagnostics, particularly in regions with limited access to healthcare infrastructure, has fueled the adoption of paper-based diagnostic devices. Technological advancements in microfluidics, biosensors, and detection methods have significantly improved the sensitivity, accuracy, and range of tests that can be performed on paper-based platforms. Furthermore, the global push for affordable and sustainable healthcare solutions has increased demand for paper diagnostics, which are cost-effective, portable, and environmentally friendly. The shift toward remote healthcare and personalized medicine, as well as the rising prevalence of infectious diseases and chronic conditions, are also contributing to market growth. As governments, NGOs, and healthcare organizations continue to invest in improving healthcare access, particularly in low-resource settings, the paper diagnostics market is expected to expand significantly.

Select Competitors (Total 44 Featured) -

  • Abcam PLC
  • Abingdon Health Ltd.
  • Acon Laboratories, Inc.
  • Alere, Inc.
  • Arkray, Inc.
  • BBI Solutions
  • Bioporto Diagnostics A/S
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cytodiagnostics Inc.
  • DCN Diagnostics
  • MilliporeSigma
  • NanoHybrids
  • SD Biosensor, Inc.
  • Siemens Healthineers
  • SurModics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Paper Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Low-Cost, Point-of-Care Testing Drives Growth in the Paper Diagnostics Market
    • Increasing Focus on Infectious Disease Testing Expands Market Opportunities for Paper-Based Diagnostic Tools
    • Technological Advancements in Microfluidics and Biosensors Enhance the Sensitivity and Accuracy of Paper Diagnostics
    • Growing Popularity of Home Testing Solutions Fuels Demand for User-Friendly, Disposable Paper Diagnostics
    • Rising Consumer Interest in Personalized Medicine and At-Home Diagnostics Strengthens the Business Case for Paper Diagnostics
    • Technological Innovations in Colorimetric and Electrochemical Detection Methods Improve the Accuracy of Paper-Based Tests
    • Growing Need for Rapid Testing During Public Health Crises Fuels Demand for Scalable Paper Diagnostics
    • Increasing Use of Paper Diagnostics in Disease Monitoring and Management Expands Market Potential in Chronic Disease Segments
    • Rising Focus on Sustainability and Biodegradability in Medical Devices Drives Adoption of Paper-Based Diagnostic Solutions
    • Technological Innovations in Immunoassay and Lateral Flow Techniques Enhance the Versatility and Speed of Paper Diagnostics
    • Growing Adoption of Paper Diagnostics in Remote and Resource-Limited Regions Strengthens Global Healthcare Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Paper Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Paper Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Lateral Flow Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Lateral Flow Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Paper Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Paper Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Paper Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Paper Diagnostics by Product - Lateral Flow Assay Kits, Dipsticks and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Paper Diagnostics by Product - Percentage Breakdown of Value Sales for Lateral Flow Assay Kits, Dipsticks and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Paper Diagnostics by End-Use - Hospitals & Clinics, Home Healthcare and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Paper Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Healthcare and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION